Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF)

Clinical Transplantation

Volumn 10, Issue 1 II, 1996, Pages 77-84

  Allison, Anthony C ^a   Eugui, Elsie M ^b  

^a DAWA Inc   (United States)

^b NONE

Author keywords

Immunosuppression; Inosine monophosphate dehydrogenase; Mycophenolate mofetil; Mycophenolic acid; Purine metabolism

Indexed keywords

CYCLOSPORIN A; DEOXYGUANOSINE TRIPHOSPHATE; ESTERASE; GLUCOCORTICOID; GUANOSINE TRIPHOSPHATE; MEMBRANE PROTEIN; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXIDOREDUCTASE; SELECTIN; TACROLIMUS;

ANTIBODY RESPONSE; ARTERY DISEASE; ARTERY MUSCLE; B LYMPHOCYTE; CELL PROLIFERATION; CELL TRANSFORMATION; CELL TYPE; CONFERENCE PAPER; CYTOSTASIS; DNA SYNTHESIS; DRUG EFFECT; DRUG HYDROLYSIS; DRUG MECHANISM; ENZYME INHIBITION; EPSTEIN BARR VIRUS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; LYMPHOMA; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PURINE METABOLISM; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DNA; ENZYME INHIBITORS; GRAFT REJECTION; GRAFT VS HOST DISEASE; GUANOSINE TRIPHOSPHATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMP DEHYDROGENASE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MUSCLE, SMOOTH, VASCULAR; MYCOPHENOLIC ACID; ORGAN TRANSPLANTATION; PURINES; SELECTINS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029918886     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. PENN I. Tumors of the immunosuppressed patient. Annu Rev Med 1988: 39: 63.
2. KLEIN G, KLEIN E. How one thing has lead to another. Annu Rev Immunol 1989: 7: 1.
3. KORSMEYER SJ. Chromosomal transiocations in lymphoid malignancies reveal several novel protooncogenes. Annu Rev Immunol 1992: 10: 785.
4. GIBLETT ER, ANDERSON JE, COHEN F, POLLARA B, MEUWISSEN HJ. Adenosine deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 1972: 2: 1067
5. ALLISON AC, HOVI T. WATTS RWE. WEBSTER ADB. Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de novo purine synthesis in lymphocyte transformation. Lancet 1975: 2: 1179.
6. GARCIA RC, LEONI P, ALLISON AC. Control of phosphoribosyl pyrophosphate synthesis in human lymphocytes. Biochem Biophys Res Commun 1977: 77: 1067.
7. EUGUI EM, ALMQUIST SJ, MULLER CD, ALLISON AC. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol 1991: 33: 161.
8. CARR SF, PAPP E, WU JC, NATSUMEDA Y. Characterization of human type I and type II IMP dehydrogenases. J Biol Chem 1993: 268 27286.
9. ALLISON AC, ALMQUIST SJ, MULLER CD, EUGUI EM. In vitro immunosuppressive effects of mycophenolic acid and an ester prodrug, RS-61443. Transplant Proc 1991: 23 (suppl 2): 10.
10. ALLISON AC, EUGUI EM. Mycophenolate mofetil (RS-61443): mode of action and effects on graft rejection. In: THOMSON AW, STARZL TF, eds. Immunosuppressive Drugs, Developments in Anti-Rejection Therapy. New York: Edward Arnold, 1994: 141.
11. BYARS NE, NAKANO G, KANG R, ALLISON AC. Oral administration of mycophenolic acid selectively depletes GTP in lymph node cells of immunized rats. 9th International Congress of Immunology. San Francisco, July 1995: 855.
12. LASKY LA. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 1992: 258: 964.
13. Wvss D, CHOI JS, LI J, et al. Conformation and function of the N-linked glycan in the adhesion domain of human CD2. Science 1995: 269: 1273.
14. ALLISOK AC, KOWALSKI WJ, MULLER CJ, WATERS RV, EUGUI EM. Mycophenolic acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosylation of adhesion molecules. Transplant Proc 1993: 2: 67.
15. AZUMA H, BINDER J, HEEMANN U, SCHMID C, TULLIUS SG, TILNEY NL. Effects of RS-61443 on functional and morphological changes in chronically rejecting rat kidney allografts. Transplantation 1995: 59: 460.
16. EUGUI EM, MIRKOVICH A, ALLISON AC. Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice. Scand J Immunol 1991: 33: 175.
17. ROSENBERG AS, SINGER A. Cellular basis of skin graft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1992: 10: 333.
18. EUGUI EM, NAKANO G, BYARS NE. Effect of mycophenolic acid on antibody titers and isotypes in mice vaccinated with influenza virus hemagglutinin. 9th International Congress of Immunology, San Francisco, July 1995: 855.
19. MIRKOVICH A. EUGUI EM. Prevention of murine graft-versus-host-disease (GVHD) by mycophenolate mofetil (CellCept®). 9th International Congress of Immunology, San Francisco, July 1995. 426.
20. PALMER DC, TSAI CC, ROODMAN ST, CODD JE, MILLER LW, SAFARIAN JE, WILLIAMS GA. Heart graft atherosclerosis. Transplantation 1985: 39: 385.
21. FOSTER MC, WENHAM PW, ROWE PA, BERDEN RP, MORGAN AG, COTTON RE, BLAMEY RW. The late results of renal transplantation and the importance of chronic rejection as a cause of graft loss. Ann R Coll Surg Engl 1989: 71: 119.
22. FOEGH ML. Chronic rejection-graft atherosclerosis. Transplant Proc 1990: 22: 119.
23. BILLINGHAM ME. Graft coronary disease: the lesions and the patients. Transplant Proc 1989: 21: 3665.
24. MORRIS RE, HOYT EG, MURPHY MP, EUGUI EM, ALLISON AC. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis. Transplant Proc 1990: 22: 1659.
25. STEELE DM, HULLETT DA, BECHSTEIN WO, KOWALSKI J, SMITH LS, KENNEDY E, ALLISON AC, SOLLINGER HW. Effects of immunosuppressive therapy on the rat aortic allograft model. Transplant Proc 1993: 25: 754.
26. RÄISÄNEN-SOKOLOWSKI A, AHO P, MYLLNÄRNIEMI M, KALLIO E, HÄYRY P. Inhibition of chronic rejection in rat aortic allografts by mycophenolic acid. Transplant Proc 1995: 27: 435.
27. GREGORY CR, HUANG X, PRATT RE, DZAU VJ, SHORTHOUSE R, BILLINGHAM ME, MORRIS RE. Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation 1995: 59: 655.
28. MCMANUS RP, O'HAIR DP, HUNTER JB, KOMOROWSKI R. Spectrum of vascular changes in primate cardiac xenografts. Transplant Proc 1993: 25: 754.
29. SAVOIE A, PERPETE C, CARPENTIER L, JONCAS J, ALFERI C. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 1994: 83: 2715.
30. BIRD AG, Cyclosporin A, lymphomata and Epstein-Barr virus. In: WHITE DJ, ed. Cyclosporin A. Amsterdam: Elsevier, 1982: 307.
31. ALFIERI C, ALLISON AC, KIEFF E. Effect of mycophenolic acid on Epstein-Barr virus infection of human lymphocytes. Antimicrob Agents Chemother 1994: 38: 126.
32. FUNG JJ, TODO S, JAIN A. DEMETRIS AJ, MCMICHAEL J, STARZL TE. The Pittsburgh randomized trial of tacrolimus vs. cyclosporine for liver transplantation. J Am Coll Surg 1995 (in press).
33. FREISE CE, HERBERT M, OSORIO RW, NIKOAI B, LOBO JR, KAUFFMAN RS, ASCHER NL, ROBERTS JP. Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation. Transplant Proc 1993: 25: 1758.